喉頭がん治療薬の世界市場レポート 2025年

喉頭がん治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.2％で41億5,000万米ドルに成長します。予測期間の成長は、標的療法や免疫療法の進歩、ゲノム医療の統合、老年人口の増加、世界の医療協力、遠隔医療の役割拡大などに起因します。予測期間の主な動向には、医学研究の進歩、免疫療法の進歩、個別化医療とバイオマーカー、併用療法、患者中心のケア、ヘルスケア政策とアクセスが含まれます。

タバコの普及率の上昇が、今後の喉頭がん治療薬市場の成長を牽引すると予測されます。タバコはニコチアナ属の植物の葉を指し、喫煙、咀嚼、嗅覚などさまざまな用途のために収穫・加工されます。タバコの摂取は喉頭がんの重大な危険因子であり、疾患の開発と治療成績の両方に大きく影響します。喉頭がん治療薬では、タバコの使用による疾患への影響とその管理への取り組みに焦点を当てています。例えば、2024年10月、米国の連邦機関である米国食品医薬品局（USFDA）が発表した「2024年全国青少年たばこ調査」では、現在、全生徒の1.1％（約225万人）がたばこ製品を使用しており、高校生の10.1％（約158万人）、中学生の5.4％（約64万人）がたばこを使用していると報告されています。さらに、2.8％（約76万人）の生徒が何らかの可燃性タバコ製品を現在使用していると回答し、3.0％（約84万人）が複数のタバコ製品を使用していると回答しました。したがって、タバコの普及率の増加が喉頭がん治療薬市場の成長を牽引しています。

化学療法に対する需要の高まりは、喉頭がん治療薬市場の今後の成長を刺激すると予想されます。化学療法は、さまざまな種類のがんを治療・管理するために薬物や薬剤を利用する治療法です。化学療法は、喉頭の一部を温存し、がん細胞の増殖を抑え、症状を緩和し、患者のQOLを高めることで、進行期喉頭がんの管理において重要な役割を果たしています。例えば、2022年1月、米国の任意健康団体である米国がん協会は、2022年の米国におけるがん生存者数を18,060,100人と推定しました。さらに2022年6月、英国を拠点とするがん慈善団体マクミラン・キャンサー・サポートのデータによると、がん患者数は2022年に300万人に達し、英国では2025年までに350万人近く、2030年までに400万人に増加すると予想されています。その結果、化学療法に対する需要の高まりが喉頭がん治療薬市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界喉頭がん治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の喉頭がん治療薬市場：成長率分析
• 世界の喉頭がん治療薬市場の実績：規模と成長, 2019-2024
• 世界の喉頭がん治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界喉頭がん治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の喉頭がん治療薬市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 免疫療法
• その他の治療法
• 世界の喉頭がん治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 世界の喉頭がん治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の喉頭がん治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門センター
• その他のエンドユーザー
• 世界の喉頭がん治療薬市場化学療法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 術前化学療法
• 補助化学療法
• 緩和化学療法
• 世界の喉頭がん治療薬市場、免疫療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チェックポイント阻害剤
• モノクローナル抗体
• がんワクチン
• 世界の喉頭がん治療薬市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射線治療
• 標的療法
• 手術

第7章 地域別・国別分析

• 世界の喉頭がん治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の喉頭がん治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 喉頭がん治療薬市場：競合情勢
• 喉頭がん治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi-Aventis LLC
• Bristol Myers Squibb
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Eli Lilly and Company
• Amgen Inc.
• C.H. Boehringer Sohn AG & Co. KG.
• Regeneron Pharmaceuticals Inc.
• Incyte Corporation
• Aurobindo Pharma Ltd.
• Cipla Inc.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 喉頭がん治療薬市場2029：新たな機会を提供する国
• 喉頭がん治療薬市場2029：新たな機会を提供するセグメント
• 喉頭がん治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Laryngeal cancer therapeutics encompass various treatments and therapeutic approaches employed to manage laryngeal cancer, a type of cancer that originates in the tissues of the larynx (voice box). The selection of treatment modalities is influenced by factors such as the stage and location of the cancer, overall health, and individual preferences.

The primary treatment types for laryngeal cancer therapeutics include chemotherapy, immunotherapy, and others. Chemotherapy involves the use of potent drugs to kill or inhibit the growth of rapidly dividing cells, including cancer cells. In the context of laryngeal cancer, chemotherapy is often utilized to shrink cancerous cells before surgical intervention. The administration routes for chemotherapy drugs include oral and parenteral, and these drugs are distributed through hospital pharmacies, online pharmacies, and retail pharmacies. End users of laryngeal cancer therapeutics include hospitals, homecare, specialty centers, and others.

The laryngeal cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides laryngeal cancer therapeutics market statistics, including laryngeal cancer therapeutics industry global market size, regional shares, competitors with a laryngeal cancer therapeutics market share, detailed laryngeal cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the laryngeal cancer therapeutics industry. This laryngeal cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The laryngeal cancer therapeutics market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing incidence of laryngeal cancer, evolution of treatment modalities, clinical trial activities, government initiatives and funding, patient awareness and education.

The laryngeal cancer therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to targeted and immunotherapy advances, genomic medicine integration, rising geriatric population, global health collaborations, expanded role of telemedicine. Major trends in the forecast period include advancements in medical research, immunotherapy advancements, personalized medicine and biomarkers, combination therapies, patient-centric care, healthcare policy and access.

The rising prevalence of tobacco is projected to drive the growth of the laryngeal cancer therapeutics market in the future. Tobacco refers to the leaves of plants from the genus Nicotiana, which are harvested and processed for various uses, including smoking, chewing, and snuffing. Tobacco consumption is a significant risk factor for laryngeal cancer and significantly influences both the disease's development and treatment outcomes. Laryngeal cancer therapeutics focus on addressing the effects of tobacco use on the disease and its management. For instance, in October 2024, the 2024 National Youth Tobacco Survey published by the US Food and Drug Administration (USFDA), a federal agency in the United States, reported that 1.1% of all students (approximately 2.25 million) currently use tobacco products, with 10.1% of high school students (about 1.58 million) and 5.4% of middle school students (around 640,000) using tobacco. Additionally, 2.8% of students (about 760,000) reported current use of any combustible tobacco product, while 3.0% (approximately 840,000) indicated using multiple tobacco products. Therefore, the increasing prevalence of tobacco is driving the growth of the laryngeal cancer therapeutics market.

The rising demand for chemotherapy is expected to stimulate growth in the laryngeal cancer therapeutics market moving forward. Chemotherapy is a medical treatment that utilizes drugs or medications to treat and manage various types of cancer. It plays a crucial role in the management of advanced-stage laryngeal cancer by preserving parts of the larynx, controlling the growth of cancer cells, alleviating symptoms, and enhancing the patient's quality of life. For example, in January 2022, the American Cancer Society, a US-based voluntary health organization, estimated that there were 18,060,100 cancer survivors in the United States in 2022. Moreover, in June 2022, data from Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of people living with cancer reached 3 million in 2022 and is expected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Consequently, the growing demand for chemotherapy is driving the growth of the laryngeal cancer therapeutics market.

Prominent companies in the laryngeal cancer treatment market are focusing on developing innovative technologies such as Zeno AI to expand their customer base, drive sales, and increase revenue. Zeno AI represents a real-time AI solution designed for cancer detection and classification in the Ear, Nose, and Throat (ENT) region. For example, WSK Medical B.V., a Netherlands-based AI software company, introduced Zeno AI in September 2022. This real-time AI solution facilitates early detection of throat cancer during endoscopic examinations, providing instant localization and classification of laryngeal lesions on endoscopic videos. Zeno AI aims to streamline the early detection and diagnosis of laryngeal cancer, reducing analysis time and enabling faster implementation of care plans.

In May 2024, Moffitt Cancer Center, a cancer treatment and research center based in the US, announced a collaboration with Fulgent Pharma. The goal of this partnership is to enhance cancer treatment through clinical development and pre-clinical co-development initiatives, merging Moffitt's clinical expertise with Fulgent's nanotherapeutics and genomics platforms to expedite personalized cancer therapies. Fulgent Pharma is a US-based innovative company that focuses on cancer therapeutics, specializing in nanoencapsulation technology and personalized oncology treatments.

Major companies operating in the laryngeal cancer therapeutics market report are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co., AbbVie Inc., Novartis AG, Bayer AG, Sanofi-Aventis LLC, Bristol Myers Squibb, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG., Regeneron Pharmaceuticals Inc., Incyte Corporation, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Limited, Seagen Inc., Exelixis Pharmaceuticals Inc., BeiGene Ltd., Taiho Pharmaceutical Co. Ltd., Genentech Inc., Mirati Therapeutics Inc.

North America was the largest region in the laryngeal cancer therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laryngeal cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the laryngeal cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The laryngeal cancer therapeutics market consists of revenues earned by entities by providing services such as diagnostic services, treatment planning and coordination, surgical interventions, radiation therapy, and chemotherapy administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The laryngeal cancer therapeutics market includes sales of radiation therapy machines, targeted therapies, immunotherapy drugs, surgical instruments, and voice prostheses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Laryngeal Cancer Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on laryngeal cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for laryngeal cancer therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The laryngeal cancer therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Chemotherapy; Immunotherapy; Other Treatments
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users
• Subsegments:
• 1) By Chemotherapy: Neoadjuvant Chemotherapy; Adjuvant Chemotherapy; Palliative Chemotherapy
• 2) By Immunotherapy: Checkpoint Inhibitors; Monoclonal Antibodies; Cancer Vaccines
• 3) By Other Treatments: Radiation Therapy; Targeted Therapy; Surgery
• Companies Mentioned: Pfizer Inc.; F. Hoffmann La Roche Ltd.; Merck & Co.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Laryngeal Cancer Therapeutics Market Characteristics

3. Laryngeal Cancer Therapeutics Market Trends And Strategies

4. Laryngeal Cancer Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Laryngeal Cancer Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Laryngeal Cancer Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Laryngeal Cancer Therapeutics Market Growth Rate Analysis
• 5.4. Global Laryngeal Cancer Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Laryngeal Cancer Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Laryngeal Cancer Therapeutics Total Addressable Market (TAM)

6. Laryngeal Cancer Therapeutics Market Segmentation

• 6.1. Global Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Immunotherapy
• Other Treatments
• 6.2. Global Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.3. Global Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.4. Global Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Centers
• Other End-Users
• 6.5. Global Laryngeal Cancer Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neoadjuvant Chemotherapy
• Adjuvant Chemotherapy
• Palliative Chemotherapy
• 6.6. Global Laryngeal Cancer Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Checkpoint Inhibitors
• Monoclonal Antibodies
• Cancer Vaccines
• 6.7. Global Laryngeal Cancer Therapeutics Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiation Therapy
• Targeted Therapy
• Surgery

7. Laryngeal Cancer Therapeutics Market Regional And Country Analysis

• 7.1. Global Laryngeal Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Laryngeal Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Laryngeal Cancer Therapeutics Market

• 8.1. Asia-Pacific Laryngeal Cancer Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Laryngeal Cancer Therapeutics Market

• 9.1. China Laryngeal Cancer Therapeutics Market Overview
• 9.2. China Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Laryngeal Cancer Therapeutics Market

• 10.1. India Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Laryngeal Cancer Therapeutics Market

• 11.1. Japan Laryngeal Cancer Therapeutics Market Overview
• 11.2. Japan Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Laryngeal Cancer Therapeutics Market

• 12.1. Australia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Laryngeal Cancer Therapeutics Market

• 13.1. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Laryngeal Cancer Therapeutics Market

• 14.1. South Korea Laryngeal Cancer Therapeutics Market Overview
• 14.2. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Laryngeal Cancer Therapeutics Market

• 15.1. Western Europe Laryngeal Cancer Therapeutics Market Overview
• 15.2. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Laryngeal Cancer Therapeutics Market

• 16.1. UK Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Laryngeal Cancer Therapeutics Market

• 17.1. Germany Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Laryngeal Cancer Therapeutics Market

• 18.1. France Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Laryngeal Cancer Therapeutics Market

• 19.1. Italy Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Laryngeal Cancer Therapeutics Market

• 20.1. Spain Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Laryngeal Cancer Therapeutics Market

• 21.1. Eastern Europe Laryngeal Cancer Therapeutics Market Overview
• 21.2. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Laryngeal Cancer Therapeutics Market

• 22.1. Russia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Laryngeal Cancer Therapeutics Market

• 23.1. North America Laryngeal Cancer Therapeutics Market Overview
• 23.2. North America Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Laryngeal Cancer Therapeutics Market

• 24.1. USA Laryngeal Cancer Therapeutics Market Overview
• 24.2. USA Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Laryngeal Cancer Therapeutics Market

• 25.1. Canada Laryngeal Cancer Therapeutics Market Overview
• 25.2. Canada Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Laryngeal Cancer Therapeutics Market

• 26.1. South America Laryngeal Cancer Therapeutics Market Overview
• 26.2. South America Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Laryngeal Cancer Therapeutics Market

• 27.1. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Laryngeal Cancer Therapeutics Market

• 28.1. Middle East Laryngeal Cancer Therapeutics Market Overview
• 28.2. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Laryngeal Cancer Therapeutics Market

• 29.1. Africa Laryngeal Cancer Therapeutics Market Overview
• 29.2. Africa Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Laryngeal Cancer Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Laryngeal Cancer Therapeutics Market Competitive Landscape
• 30.2. Laryngeal Cancer Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Laryngeal Cancer Therapeutics Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi-Aventis LLC
• 31.3. Bristol Myers Squibb
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. C.H. Boehringer Sohn AG & Co. KG.
• 31.10. Regeneron Pharmaceuticals Inc.
• 31.11. Incyte Corporation
• 31.12. Aurobindo Pharma Ltd.
• 31.13. Cipla Inc.
• 31.14. Hikma Pharmaceuticals plc
• 31.15. Amneal Pharmaceuticals LLC

32. Global Laryngeal Cancer Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Laryngeal Cancer Therapeutics Market

34. Recent Developments In The Laryngeal Cancer Therapeutics Market

35. Laryngeal Cancer Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Laryngeal Cancer Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Laryngeal Cancer Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Laryngeal Cancer Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer